Abstract
Background: Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods: Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results: In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions: The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.
| Original language | English |
|---|---|
| Article number | 169 |
| Journal | BMC Cancer |
| Volume | 18 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb 9 2018 |
Fingerprint
Keywords
- Cancer prevalence
- Italy
- Projections
- Survivors
ASJC Scopus subject areas
- Oncology
- Genetics
- Cancer Research
Cite this
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020. / Guzzinati, Stefano; Virdone, Saverio; De Angelis, Roberta; Panato, Chiara; Buzzoni, Carlotta; Capocaccia, Riccardo; Francisci, Silvia; Gigli, Anna; Zorzi, Manuel; Tagliabue, Giovanna; Serraino, Diego; Falcini, Fabio; Casella, Claudia; Russo, Antonio Giampiero; Stracci, Fabrizio; Caruso, Bianca; Michiara, Maria; Caiazzo, Anna Luisa; Castaing, Marine; Ferretti, Stefano; Mangone, Lucia; Rudisi, Giuseppa; Sensi, Flavio; Mazzoleni, Guido; Pannozzo, Fabio; Tumino, Rosario; Fusco, Mario; Ricci, Paolo; Gola, Gemma; Giacomin, Adriano; Tisano, Francesco; Candela, Giuseppa; Fanetti, Anna Clara; Pala, Filomena; Sardo, Antonella Sutera; Rugge, Massimo; Botta, Laura; Maso, Luigino Dal.
In: BMC Cancer, Vol. 18, No. 1, 169, 09.02.2018.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
AU - Guzzinati, Stefano
AU - Virdone, Saverio
AU - De Angelis, Roberta
AU - Panato, Chiara
AU - Buzzoni, Carlotta
AU - Capocaccia, Riccardo
AU - Francisci, Silvia
AU - Gigli, Anna
AU - Zorzi, Manuel
AU - Tagliabue, Giovanna
AU - Serraino, Diego
AU - Falcini, Fabio
AU - Casella, Claudia
AU - Russo, Antonio Giampiero
AU - Stracci, Fabrizio
AU - Caruso, Bianca
AU - Michiara, Maria
AU - Caiazzo, Anna Luisa
AU - Castaing, Marine
AU - Ferretti, Stefano
AU - Mangone, Lucia
AU - Rudisi, Giuseppa
AU - Sensi, Flavio
AU - Mazzoleni, Guido
AU - Pannozzo, Fabio
AU - Tumino, Rosario
AU - Fusco, Mario
AU - Ricci, Paolo
AU - Gola, Gemma
AU - Giacomin, Adriano
AU - Tisano, Francesco
AU - Candela, Giuseppa
AU - Fanetti, Anna Clara
AU - Pala, Filomena
AU - Sardo, Antonella Sutera
AU - Rugge, Massimo
AU - Botta, Laura
AU - Maso, Luigino Dal
PY - 2018/2/9
Y1 - 2018/2/9
N2 - Background: Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods: Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results: In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions: The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.
AB - Background: Estimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis. Methods: Data were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software. Results: In 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis. Conclusions: The number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.
KW - Cancer prevalence
KW - Italy
KW - Projections
KW - Survivors
UR - http://www.scopus.com/inward/record.url?scp=85041834446&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041834446&partnerID=8YFLogxK
U2 - 10.1186/s12885-018-4053-y
DO - 10.1186/s12885-018-4053-y
M3 - Article
AN - SCOPUS:85041834446
VL - 18
JO - BMC Cancer
JF - BMC Cancer
SN - 1471-2407
IS - 1
M1 - 169
ER -